LIVE
NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

GLENMARK

NSEBSE
F&O
Glenmark Pharmaceuticals Limited
Healthcare· Pharmaceuticals & Biotechnology· INE935A01035· Scrip: 532296
ENहिन्दीગુજરાતીमराठी
₹२,३७१.४०
▼ 46.50 (-1.92%)
6/5/2026, 3:28:22 pm
NSE
₹२,३७१.४०
▼ ४६.५०
-१.९२%
BSE
₹२,३७३.७५
▲ ४६.३०
+०.००%
1,3731,6371,9022,1662,43005-0607-0108-2810-2712-2302-2004-2905-06
२४५ व्यापार दिन · 1Y कालावधी
आज
उघडणे२,४३५.००
उच्चांक२,४४०.००
नीचांक२,३५४.९०
मागील बंद२,४१७.९०
व्हॉल्यूम१०.९८L
मूल्य₹२६४.८Cr
L: 2,354.90H: 2,440.00
52 आठवडे
नीचांक₹१,३५५.४०
उच्चांक₹२,४७४.००
९१% 52 आठवड्यांच्या श्रेणीत
माहिती
दर्शनी मूल्य₹१
सूचीबद्ध2000-02-07
ISININE935A01035
SeriesA
BSE स्क्रिप532296

मुख्य निर्देशक

1D
-1.92%
1W
-1.34%
1M
+12.86%
3M
+20.52%
6M
+28.14%
मूल्यांकन
P/E (Qtr Ann.)४८.०८
P/Sales५.०४
वाढ (तिमाही)
PAT-1.82%
EPS-1.75%
लाभांश
वाढ+0.00%
TTM EBITDA
₹2525 Cr
TTM PAT
₹-58 Cr
TTM EPS
₹-२.२२

तिमाही वित्तीय

महसूल
EBITDA
PAT
EPS
0 Cr866 Cr1732 Cr2598 Cr3464 Cr22-1223-0323-0923-1224-0324-0624-0924-12₹9.7₹-15.2₹-2.9₹-12.4₹-43.2₹16.1₹12.6₹12.3
तिमाहीमहसूलExpensesEBITDAPBTPATEPS
2024-12-313388 Cr2962 Cr579 Cr456 Cr348 Cr₹12.33
2024-09-303434 Cr3001 Cr593 Cr473 Cr354 Cr₹12.55
2024-06-302330 Cr1767 Cr671 Cr618 Cr454 Cr₹16.08
2024-03-313063 Cr2859 Cr682 Cr531 Cr-1214 Cr₹-43.18
2023-12-312507 Cr2997 Cr-374 Cr-521 Cr-331 Cr₹-12.45
2023-09-303207 Cr3008 Cr17 Cr-124 Cr-64 Cr₹-2.90
2023-03-313374 Cr3025 Cr-344 Cr-491 Cr-403 Cr₹-15.18
2022-12-313464 Cr3103 Cr633 Cr471 Cr291 Cr₹9.66

शेअरहोल्डिंग नमुना

सध्याचे — 2026-03-31
46.6%प्रवर्तक
प्रवर्तक46.6%
FII20.3%
DII19.3%
सार्वजनिक53.4%
सरकार0.0%
प्रवर्तक होल्डिंग ट्रेंड
46.6%24-0646.6%24-0946.6%24-1246.6%25-0346.6%25-0946.6%25-1246.6%26-03

कॉर्पोरेट कार्यवाही

एक्स-तारीखप्रकारउद्देश
2025-10-03DividendInterim Dividend - Rs 2.50 Per Share
2025-09-15DividendDividend - Rs 2.50 Per Share
2024-09-13DividendDividend - Rs 2.50 Per Share
2023-09-18DividendDividend - Rs 2.50 Per Share
2022-09-12DividendAnnual General Meeting/Dividend - Rs 2.50 Per Share
2021-09-08Dividend Annual General Meeting/Dividend - Rs 2.50 Per Share
2020-09-17Dividend Annual General Meeting/Dividend - Rs 2.50 Per Share
2019-09-19Dividend Annual General Meeting/Dividend - Rs 2 Per Share
2018-09-19Dividend Annual General Meeting/Dividend Rs 2 Per Share
2017-09-20Dividend Annual General Meeting/Dividend - Rs 2/- Per Share
2016-08-03Dividend Annual General Meeting/ Dividend - Rs 2/- Per Share
2015-09-10Dividend Annual General Meeting/ Dividend - Rs 2/- Per Share
2014-07-10DividendAnnual General Meeting / Dividend - Rs 2/- Per Share
2013-07-18DividendAnnual General Meeting / Dividend - Rs 2/- Per Share
2012-07-19DividendAnnual General Meeting / Dividend Rs 2 Per Share
2011-07-28DividendAnnual General Meeting And Dividend Re.0.40 Per Share
2010-09-16DividendAnnual General Meeting And Dividend Re.0.40 Per Share
2009-09-10OtherAgm/Div-Re.0.40 Per Share
2008-09-18OtherAnnual General Meeting
2007-11-07DividendInterim Dividend-70% Purpose Revised

उत्पन्न विवरण

Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
14 Nov 2025NSE20K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
14 Aug 2025NSE14K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
23 May 2025NSE18K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
14 Feb 2025NSE18K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
14 Feb 2024NSE20K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
10 Nov 2023NSE24K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
21 Sept 2023NSE11K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
19 May 2023NSE22K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation
10 Feb 2023NSE20K chars
Read →
Further to our letter dated 03rd November, 2022 and pursuant to Regulation 30(6) read with Part A of...
18 Nov 2022NSE1K chars
Read →
Further to our communication dated November 11, 2022, attached is a copy of the presentation to be m...
17 Nov 2022NSE42K chars
Read →
Audio recording of Q2 of FY 2022-23 Earnings Call
14 Nov 2022NSE1K chars
Read →
Enclosed please find herewith the details of Earnings Call slated for Monday, November 14, 2022 at 9...
3 Nov 2022NSE2K chars
Read →
Further to our letter dated 01st August, 2022 and pursuant to Regulation 30(6) read with Part A of S...
17 Aug 2022NSE2K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Audio recording of Q1 of FY 2022-23...
12 Aug 2022NSE1K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutiona...
3 Jun 2022NSE1K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange about Audio recording of Q4 & FY22 Earnin...
30 May 2022NSE1K chars
Read →
Glenmark Pharmaceuticals Limited has informed the Exchange regarding "Investor Presentation of the C...
12 Jan 2016NSE
Read →
Glenmark Pharmaceuticals Limited has submitted to the Exchange a copy of the Investor Presentation o...
14 Jan 2015NSE
Read →

किंमत इतिहास

तारीखउघडणेउच्चांकनीचांकबंदव्हॉल्यूम
2026-05-06२,४३५.००२,४४०.००२,३५४.९०२,३७७.६०११.०९L
2026-05-05२,३८४.३०२,४३०.००२,३६०.००२,४१७.९०९.१८L
2026-05-04२,४३४.३०२,४३८.८०२,३८२.६०२,३९३.७०४.५१L
2026-04-30२,४००.१०२,४५५.९०२,३८५.६०२,४०६.३०७.९३L
2026-04-29२,४१८.७०२,४७४.००२,४०३.७०२,४१३.९०६.१७L
2026-04-28२,३२८.१०२,४२७.४०२,३२७.३०२,४०३.७०१५.३८L
2026-04-27२,३१२.००२,३३९.९०२,२९०.९०२,३२५.१०४.६३L
2026-04-24२,३५१.००२,३७२.८०२,२८३.२०२,२९९.५०८.३८L
2026-04-23२,२४७.९०२,३५९.४०२,२१२.१०२,३३५.००१७.०४L
2026-04-22२,२३३.१०२,२४७.००२,२०४.८०२,२४०.००३.२३L
2026-04-21२,२२१.९०२,२४५.००२,२१५.२०२,२३३.१०२.५५L
2026-04-20२,२४९.५०२,२५०.५०२,२१०.५०२,२३०.७०४.०८L
2026-04-17२,२४९.५०२,२७४.९०२,२४०.९०२,२४९.५०३.६६L
2026-04-16२,२६७.००२,२७३.८०२,२२८.६०२,२४९.५०४.३४L
2026-04-15२,२३०.९०२,२६५.००२,२०५.००२,२५८.४०६.१७L
2026-04-13२,१५३.४०२,२०५.००२,११५.१०२,१९३.१०७.२४L
2026-04-10२,१७३.९०२,१९८.९०२,१४८.९०२,१६३.२०६.६९L
2026-04-09२,१७३.५०२,१८६.२०२,१४२.००२,१६९.१०६.१३L
2026-04-08२,१६५.००२,१८७.००२,१२९.६०२,१७३.५०५.४५L
2026-04-07२,१००.००२,१३८.००२,०६८.२०२,११४.१०३.८८L
2026-04-02२,०८५.००२,०९८.४०१,९६६.५०२,०९१.८०९.७०L
2026-04-01२,१८०.००२,२३८.४०२,०८५.००२,१०१.१०१०.१२L
2026-03-27२,१६८.५०२,१८८.४०२,१४६.६०२,१७०.५०७.४४L
2026-03-25२,१२०.००२,१७९.७०२,१०२.४०२,१६८.५०४.४७L
2026-03-24२,१०३.००२,१३७.१०२,०७८.३०२,०९५.७०५.४०L
2026-03-20२,११४.१०२,१९०.९०२,११०.१०२,१८०.१०५.९७L
2026-03-19२,१७४.००२,१७६.६०२,०८७.४०२,०९७.५०४.६५L
2026-03-18२,१४५.९०२,२३७.६०२,१४३.१०२,१८६.३०८.८३L
2026-03-17२,१७९.९०२,१८४.७०२,१३६.००२,१४५.९०७.७४L
2026-03-16२,१७२.५०२,२१४.८०२,१४५.००२,१७५.४०५.२९L

वारंवार विचारले जाणारे प्रश्न

बद्दल

ग्लेनमार्क फार्मास्युटिकल्स लिमिटेड, मुंबई येथे मुख्यालय असलेली भारत-आधारित फार्मास्युटिकल कंपनी, देशांतर्गत आणि आंतरराष्ट्रीय बाजारपेठेत सक्रिय फार्मास्युटिकल घटक (APIs) आणि फॉर्म्युलेशनसह जेनेरिक आणि विशेष औषधांच्या श्रेणीचे डिझाइन, उत्पादन आणि मार्केटिंग करते. मुख्य उत्पादनांमध्ये हृदय व रक्तवाहिन्यासंबंधी, मध्यवर्ती मज्जासंस्थेचे विकार आणि ऑन्कोलॉजीवरील उपचारांचा समावेश होतो.

Advertisement
BOARD OF DIRECTORS
Anurag Mantri
Executive Director
DEPARTED
Anurag Mantri
Whole-time Director
Milind Sarwate
Independent Director
DEPARTED
Pradeep Kumar Sinha
Independent Director
Rajesh Desai
Independent Director
DEPARTED
Vijayalakshmi Rajaram Iyer
Independent Director